Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Vista Outdoor Inc (VSTO), Curis, Inc. (CRIS): First Eagle Investment Management’s Latest Bullish Plays

Page 1 of 2

Jean-Marie Eveillard‘s First Eagle Investment Management has recently disclosed two moves involving Vista Outdoor Inc (NYSE:VSTO), and Curis, Inc. (NASDAQ:CRIS). The fund has initiated a passive stake in Vista Outdoors disclosing ownership of 6.93 million shares in a new filing, which represents 10.85% of the company’s outstanding stock. In Curis, the investor raised its stake to 24.01 million shares from 20.62 million shares, the increased stake amassing 18.72% of the company’s common stock.

Vista Outdoor

Mr. Eveillard has over 50 years of experience in the investment world, starting as an analyst at Societe Generale in 1962. Later, he became the portfolio manager of SoGen International Fund in the US; the firm changed its name to First Eagle Global in 2000. Currently, he serves as the senior advisor for First Eagle Funds. The investment management team currently manages five mutual funds: First Eagle Global Fund, First Eagle Overseas Fund, First Eagle US Value Fund, First Eagle Gold Fund, and First Eagle Global Income Builder Fund. The firm also has two other funds: First Eagle High Yield Fund and First Eagle Fund of America. As of the end of 2014, First Eagle Investmen Management had over $41 billion in equities, holding stakes in some of the largest companies across several sectors. The fund’s largest holdings were represented by Microsoft Corporation (NASDAQ:MSFT), Oracle Corporation (NYSE:ORCL), and Comcast Corporation (NASDAQ:CMCSK).

Let’s take a look at First Eagles’ latest acquisition, Vista Outdoor Inc (NYSE:VSTO). The $2.60 billion company went public around a month ago as a spin-off from Alliant Techsystems (ATK), an aerospace, defense, and sporting goods company. Earlier this year, ATK merged its aerospace and defense businesses with Orbital Sciences Corporation, forming Orbital ATK Inc (NYSE:OA), while its sporting goods segment was spun-off as Vista Outdoor Inc (NYSE:VSTO). Since its IPO, Vista Outdoor’s stock has gained nearly 20%. A couple of weeks ago, the company’s board of directors authorized a $200 million share buyback program, although the timing is yet to be determined, and will depend on the stock price and financial results. Since the company has gone public, First Eagle is currently the only fund that reported holding shares of Vista Outdoor Inc (NYSE:VSTO) among funds that we track.

On the other hand, Curis, Inc. (NASDAQ:CRIS) has been included in the investor’s 13F portfolio for almost a decade. According to the Securities and Exchange Commission’s records, the company has held Curis since at least the second quarter of 2006, when First Eagle made its first 13F filing. The stock has gained some 130% since then, although it still remains a small-cap company with a market cap of $327.90 million. Curis, Inc. (NASDAQ:CRIS) is a biotech company that is engaged in developing and selling drug candidates for the treatment of human cancers. First Eagle is by far the largest shareholder of Curis, Inc. (NASDAQ:CRIS) among funds that we track, with Samuel Isaly‘s Orbimed Advisors, which owned 1.95 million shares as of the end of 2014, being the next biggest shareholder. In fact, only eight investors from our database disclosed long positions in the company, including billionaires Israel Englander, Paul Tudor Jones, and Ken Griffin.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!